Memphis Pharmaceuticals (MPCI.CA) - Central Auditing Organization Report
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Central Auditing Organization Report on the financial statements for the financial period ending 31/12/2024.
Central Auditing Organization Report (5,706 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Central Auditing Organization Report on the financial statements for the financial period ending 31/12/2024.
Central Auditing Organization Report (5,706 KB)
Comments